Confusion from Overlapping SOPs: A Hidden Compliance Risk in Pharma
Confusion from Overlapping SOPs: A Hidden Compliance Risk in Pharma Resolving Confusion from Overlapping SOPs in GMP Environments Introduction to the Audit Finding 1. Nature of the Issue In pharmaceutical operations, multiple departments often draft SOPs independently. When different SOPs cover overlapping or identical processes without coordination, it results in conflicting instructions, duplications, and ambiguity….
Read More “Confusion from Overlapping SOPs: A Hidden Compliance Risk in Pharma” »